On April 26, 2012, Pfizer, Inc., held its 2012 Annual Meeting of Shareowners in Morristown, New Jersey, and David Ridenour was in attendance. With the fate of the Affordable Care Act and its individual mandate now in question, David Ridenour asks Pfizer Chairman and Chief Executive Officer Ian Read and fellow members of the Board of Directors about the company's attitude towards free-market health care reforms. Read lays out the pharmaceutical giant's free-market objectives and hopes for the industry. Ridenour closes the dialogue by urging Read and the directors to aggressively pursue these objectives if the country is given a second chance at health care reform and to fight for free-market policies. For greater discussion of these issues, please visit: www.nationalcenter.org http www.facebook.com
Tags: David Ridenour, NCPPR, Pfizer, Ian Read, Affordable Care Act, health care reform, free-market, individual mandate, shareholder activism, shareholder meeting
No comments:
Post a Comment